Leukine

Active Ingredient(s): Sargramostim, GM-CSF
FDA Approved: * March 5, 1991
Pharm Company: * BERLEX LABS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Leukine Overview

Sargramostim (tradename Leukine) is a recombinant granulocyte macrophage colony-stimulating factor (GM-CSF) that functions as an immunostimulator. Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Pharmacology 5 Chemistry 6 History 7 References Medical uses Sargramostim is primarily used for myeloid reconstitution after autologous or allogeneic bone marrow transplantation. It is also used to treat neutropenia induced by chemotherapy during the treatment of acute myeloid...

Read more Leukine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sargramostim

Recent Leukine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sargramostim, GM-CSF
  • Injection: 250mcg, 500mcg/ml
  • Vial: 250ug/ml, 500ug/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Leukine: (5 results)

Sorted by National Drug Code
  • 0024-5843 Leukine 250 ug/ml Intravenous; Subcutaneous Injection, Powder, for Solution by Sanofi-aventis U.S. LLC
  • 0024-5844 Leukine 500 ug/ml Intravenous; Subcutaneous Liquid by Sanofi-aventis U.S. LLC
  • 58468-0180 Leukine 250 ug/ml Intravenous; Subcutaneous Injection, Powder, for Solution by Genzyme Corporation
  • 71837-5843 Leukine 250 ug/ml Intravenous; Subcutaneous Injection, Powder, for Solution by Partner Therapeutics, Inc
  • 71837-5844 Leukine 500 ug/ml Intravenous; Subcutaneous Liquid by Partner Therapeutics, Inc

Other drugs which contain Sargramostim, GM-CSF or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA